A AddLife AB
A
Fermé
165.1 1.54
Résumé
Variation du prix de l'action
24h
Min
160.8
Max
163.1
Revenu | 109M 236M |
|---|---|
Ventes | 76M 2.7B |
P/E Moyenne du Secteur | 32.352 95.593 |
BPA | 1.06 |
Rendement du dividende | 0.96 |
Marge bénéficiaire | 8.673 |
Employés | 2,360 |
EBITDA | 14M 437M |
Rendement du dividende Moyenne du Secteur | 0.96% 2.47% |
|---|
Capitalisation Boursière | -12M 19B |
|---|---|
Ouverture précédente | 163.56 |
Clôture précédente | 165.1 |
AddLife AB Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
Actualités Associées
Comparaison
Variation de prix
AddLife AB prévision
Éléments financiers
Frais Généraux et Administratifs
Dépenses d'exploitation
Résultat avant impôt
Ventes
Coût des ventes
Marge brute des ventes
Charges d'intérêt sur la dette
EBITDA
Bénéfice d'exploitation
$
À Propos AddLife AB
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
